000-21863 | 04-3030815 | |
(Commission File Number) | (IRS Employer Identification No.) |
4 Maguire Road, Lexington, Massachusetts | 02421 | |
(Address of Principal Executive Offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 Regulation FD Disclosure. | ||||||||
Item 9.01 Financial Statements and Exhibits. | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EX-99.1 Press Release dated December 12, 2006 | ||||||||
EX-99.2 Press Release dated December 12, 2006 |
(d) | Exhibits: |
99.1 | Press Release issued by the registrant on December 12, 2006, furnished herewith. | ||
99.2 | Press Release issued by the registrant on December 12, 2006, furnished herewith. |
EPIX PHARMACEUTICALS, INC. |
||||
December 12, 2006 | By: | /s/ Kim C. Drapkin | ||
Kim C. Drapkin | ||||
Chief Financial Officer | ||||